Current Title and Health Information for Treasure Seeker's Asher


Asher's Pedigree


DPCA WAC - 2015.05.23 - Cavalier Doberman Pinscher Club Working Aptitude Evaluation - Judge John Schoeneman

BH - 2015.09.18 - Black River IPO Club, Angier NC - Judge Al Govednik

IPO1 - 2016.11.12 - Raleigh Schutzhund Association, Rougemont, NC - Judge Arthur Collins - 92-90-90a

IPO2 - 2017.10.07 - United Doberman Club Fall Classic, Huron, OH - Judge Al Govednik - 85-73-85a

IPO3 - 2018.03.24 - Raleigh Schutzhund Association, Rougemont, NC - Judge Arthur Collins - 89-70-92a


Potential purchasers should become educated about the genetic disorders that are most common in the Doberman.  Responsible breeders will strenuously test their breeding stock.  

Some tests, once performed, are considered good for the life of the dog.  For the Doberman, these one time tests are hip/elbows, eyes, VWD, PDK4, DCM2, RD, and other genetic screenings.  Other tests should be repeated annually or prior to each breeding.  For the Doberman, the tests that should be repeated annually include complete blood panel to evaluate kidney, liver, and thyroid function, echo, and 24-hour Holter monitor (EKG).

View Asher's OFA recorded results.  Detailed documentation available on request.

The PDK4 (DCM1)  and DCM2 mutations are two of several possible genetic causes of Dilated Cardiomyopathy in the Doberman Pinscher. The presence or absence of these mutations does not predict that Asher or Asher's offspring will or will not die from cardiomyopathy. They are  a screening tool to be used in combination with regular Echocardiogram and Holter monitoring.  Please visit this NCSU dilated cardiomyopathy webinar for the most up-to-date information about the use of PDK4 and DCM2 genetic screening for Dobermans.